| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Dual specificity protein phosphatase 13A (48-98 aa) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
DUSP13A |
| Gene ID: |
128854680/51207 |
| Uniprot ID: |
DS13A_HUMAN |
| Immunogen Region: |
48-98 aa |
| Specificity: |
This antibody detects endogenous levels of MDSP at Human/Mouse |
| Immunogen: |
Synthesized peptide derived from the human MDSP at the amino acid range 48-98 |
| Function | Probable protein tyrosine phosphatase. Has phosphatase activity with synthetic substrates. Has a phosphatase activity-independent regulatory role in MAP3K5/ASK1-mediated apoptosis, preventing MAP3K5/ASK1 inhibition by AKT1. Shows no phosphatase activity on MAPK1/ERK2, MAPK8/JNK, MAPK14/p38 and MAP3K5/ASK1. |
| Protein Name | Dual Specificity Protein Phosphatase 13aDusp13aBranching-Enzyme Interacting DspMuscle-Restricted DspMdsp |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Dual Specificity Protein Phosphatase 13a antibodyAnti-Dusp13a antibodyAnti-Branching-Enzyme Interacting Dsp antibodyAnti-Muscle-Restricted Dsp antibodyAnti-Mdsp antibodyAnti-DUSP13A antibodyAnti-BEDP antibodyAnti-DUSP13 antibodyAnti-MDSP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
